摘要目的 探讨植入型心电监测仪(ICM)在长程监测领域的临床价值.方法 入选2016年2月至2017年11月北京医院心内科因不明原因晕厥或心悸患者30例,均植入新一代植入型心电监测仪Reveal LINQ进行长程监测.结果 入选30例患者(晕厥查因27例,心悸查因3例),平均随访(7.6±3.5)个月,12例再发晕厥或前兆晕厥,明确诊断9例,诊断率为75.0％,其中心源性晕厥占66.7％.30例患者监测到7例发作房性心动过速(房速)/心房颤动(房颤),其中无症状房颤占28.6％.诊断1例阵发性室上性心动过速并接受导管消融治疗.结论 植入型心电监测仪能够长程、连续、完整、精确地记录心电活动,为临床诊断提供帮助.

abstractsObjective To evaluate the clinical value of the insertable cardiac monitor(ICM)in the field of long-term monitoring.Methods A total of 30 patients with syncope or palpitation from February 2016 to November 2017 were implanted with ICM (Reveal LINQ LNQ11,Medtronic Inc.).Results During the monitoring period (7.6 ± 3.5) months,a total of 12 patients had recurrent syncope or pre-syncope,the ICM-guided diagnosis rate was 75.0％,of which 66.7％ was cardiogenic syncope.Seven patients were found to have atrial tachycardia/atrial fibrillation,of which asymptomatic atrial fibrillation accounted for 28.6％.One patient was diagnosed with paroxysmal supraventricular tachycardia.Conclusion ICM can long-term monitor the cardiac electrical activity and provide evidence for clinical diagnosis.